Medtronic vs Vertex Pharmaceuticals
Medtronic (MDT), health care, and Vertex Pharmaceuticals (VRTX), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Vertex Pharmaceuticals is worth $135.4B on the stock market and Medtronic $132.2B: Vertex Pharmaceuticals is valued at 2% more. Medtronic trades at 25.4 times earnings and Vertex Pharmaceuticals at 34.4; operating margins in their latest fiscal years were 17.8% and 34.8%. Over the past year Medtronic's share price has moved +2.06% and Vertex Pharmaceuticals's +23.5%.
Key facts
- Medtronic market value
- $132.2B
- Vertex Pharmaceuticals market value
- $135.4B
- Medtronic P/E
- 25.4
- Vertex Pharmaceuticals P/E
- 34.4
- Medtronic revenue
- $36.4BFY to 2026-04-24
- Vertex Pharmaceuticals revenue
- $12BFY to 2025-12-31
- Superinvestors holding both
- 1
Market values as of .
| Measure | Medtronic | Vertex Pharmaceuticals |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2026-04-24 | 2025-12-31 |
| Size | ||
| Market cap | $132.2Blower | $135.4Bhigher |
| Revenue | $36.4Bhigher | $12Blower |
| Earnings | $4.8Bhigher | $4Blower |
| Employees | 95,000higher | 6,400lower |
| Total assets | $93Bhigher | $25.6Blower |
| Valuation | ||
| P/E | 25.4lower | 34.4higher |
| P/S | 3.6lower | 11.3higher |
| P/B | — | 6.5 |
| Dividend yield | — | 0.00% |
| Profitability | ||
| Operating margin | 17.8%lower | 34.8%higher |
| Balance sheet | ||
| Net assets | $49.5Bhigher | $18.7Blower |
| Total liabilities | $43Bhigher | $7Blower |
| Total debt | $28B | — |
| Cash on hand | $1.9Blower | $5.1Bhigher |
| Price change | ||
| Today | +0.43%higher | -0.68%lower |
| 1 year | +2.06%lower | +23.5%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (1)
- Ken Griffin0.2% / 0.1%
Medtronic only (9)
- Matthew McLennan1.9%
- Diamond Hill team1.4%
- Howard Gleicher1.2%
- Richard Pzena0.8%
- Mark Boyar0.4%
- Dodge & Cox team0.3%
- Mairs & Power team0.3%
- David Shaw (founder)0.2%
- Ray Dalio (founder)0.2%
Vertex Pharmaceuticals only (4)
Percentages are each holding's share of that investor's reported portfolio (under "Both": Medtronic / Vertex Pharmaceuticals). Who owns MDT · Who owns VRTX
More on Medtronic
Further comparisons
Medtronic against its closest peers
Vertex Pharmaceuticals against its closest peers
Learn
Questions and answers
Which is bigger, Medtronic or Vertex Pharmaceuticals?
By market value, Vertex Pharmaceuticals is the larger: $135.4B against $132.2B for Medtronic. By revenue in its latest fiscal year, Medtronic is the larger: $36.4B against $12B for Vertex Pharmaceuticals.
Which has the higher P/E ratio?
Vertex Pharmaceuticals: 34.4, against 25.4 for Medtronic. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Vertex Pharmaceuticals: 34.8%, against 17.8% for Medtronic. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which superinvestors own both Medtronic and Vertex Pharmaceuticals?
In their latest 13F filings, Ken Griffin holds both.
Cite this page
Funkfolio, “Medtronic vs Vertex Pharmaceuticals”, data as of 17 November 2026. https://funkfolio.com/compare/mdt-vs-vrtx
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.